Lpl Financial LLC Ionis Pharmaceuticals Inc Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Lpl Financial LLC holds 42,620 shares of IONS stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,620

Previous 51,414 17.1%

Holding current value

$1.45 Million

Previous $2.45 Million 30.33%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$40.06 - $51.86 $352,287 - $456,056	-8,794 Reduced 17.1%	42,620 $1.71 Million
Q2 2024 Aug 07, 2024	SELL	$36.45 - $47.7 $1.03 Million - $1.35 Million	-28,308 Reduced 35.51%	51,414 $2.45 Million
Q1 2024 May 10, 2024	SELL	$42.03 - $53.55 $318,461 - $405,748	-7,577 Reduced 8.68%	79,722 $3.46 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $237,907 - $283,087	5,483 Added 6.7%	87,299 $4.42 Million
Q3 2023 Nov 13, 2023	SELL	$38.5 - $47.13 $8,431 - $10,321	-219 Reduced 0.27%	81,816 $3.71 Million
Q2 2023 Jul 31, 2023	BUY	$34.73 - $43.33 $452,913 - $565,066	13,041 Added 18.9%	82,035 $3.37 Million
Q1 2023 May 10, 2023	SELL	$33.58 - $41.2 $171,425 - $210,326	-5,105 Reduced 6.89%	68,994 $2.47 Million
Q4 2022 Feb 07, 2023	SELL	$37.12 - $46.52 $23,793 - $29,819	-641 Reduced 0.86%	74,099 $2.8 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $268,459 - $357,505	-7,347 Reduced 8.95%	74,740 $3.31 Million
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $395,296 - $536,038	-12,466 Reduced 13.18%	82,087 $3.04 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $175,903 - $218,054	5,887 Added 6.64%	94,553 $3.5 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $129,356 - $177,290	5,051 Added 6.04%	88,666 $2.7 Million
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $814,988 - $985,324	24,299 Added 40.97%	83,615 $2.8 Million
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $139,299 - $190,559	4,033 Added 7.3%	59,316 $2.37 Million
Q1 2021 May 14, 2021	BUY	$42.51 - $63.78 $93,692 - $140,571	2,204 Added 4.15%	55,283 $2.49 Million
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $145,956 - $194,189	3,222 Added 6.46%	53,079 $3 Million
Q3 2020 Nov 09, 2020	BUY	$47.45 - $62.95 $173,856 - $230,648	3,664 Added 7.93%	49,857 $2.37 Million
Q2 2020 Aug 13, 2020	SELL	$46.85 - $61.05 $30,686 - $39,987	-655 Reduced 1.4%	46,193 $2.72 Million
Q1 2020 May 14, 2020	BUY	$41.6 - $63.4 $33,113 - $50,466	796 Added 1.73%	46,848 $2.22 Million
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $2,315 - $2,806	-43 Reduced 0.09%	46,052 $2.78 Million
Q3 2019 Nov 13, 2019	BUY	$59.06 - $72.15 $14,233 - $17,388	241 Added 0.53%	46,095 $2.76 Million
Q2 2019 Aug 09, 2019	BUY	$62.09 - $86.14 $91,769 - $127,314	1,478 Added 3.33%	45,854 $2.95 Million
Q1 2019 May 08, 2019	SELL	$52.92 - $81.17 $45,034 - $69,075	-851 Reduced 1.88%	44,376 $3.6 Million
Q4 2018 Feb 07, 2019	BUY	$43.37 - $59.54 $30,966 - $42,511	714 Added 1.6%	45,227 $2.45 Million
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $57,587 - $72,119	-1,343 Reduced 2.93%	44,513 $2.3 Million
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $9,889 - $12,370	-244 Reduced 0.53%	45,856 $1.91 Million
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $201,754 - $251,963	-4,577 Reduced 9.03%	46,100 $2.03 Million
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $325,189 - $416,281	6,465 Added 14.62%	50,677 $2.55 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $1.69 Million - $2.21 Million	37,083 Added 520.17%	44,212 $2.24 Million
Q2 2017 Aug 14, 2017	BUY	N/A	7,129	7,129 $363,000

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Ionis Pharmaceuticals Inc Transaction History